A revolution in treatment of HFrEF with a SGLT2 inhibitor
This video was recorded at ESC 2019 in Paris, France, on September 1, 2019.
Prof. Subodh Verma, MD, PhD is a cardiac surgeon‐scientist at St Michael’s Hospital in Toronto and Professor at the University of Toronto. He is a trained pharmacist with a PhD in cardiovascular pharmacology from the University of British Columbia.
This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.
The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.
Share this page with your colleagues and friends: